Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Distal small bowel resection with preservation of the terminal ileum suppresses hepatic gluconeogenesis <i>via</i> the <i>Prevotellaceae_NK3B31_group</i>-mediated 7-KLCA-FXR axis.

World journal of gastroenterology·2025

Same author

Skeletal muscle gauge: A superior predictor of neoadjuvant chemoimmunotherapy efficacy in locally advanced gastric cancer.

Clinical nutrition ESPEN·2025

Same author

Discovery and Biomimetic Syntheses of Phloroglucinol-Monoterpene-Triketone Hybrids from <i>Chamelaucium uncinatum</i> with Hypoglycemic Activity.

Organic letters·2025

Same author

Dimeric Acylphloroglucinol Derivatives with Anti-MRSA Activities from <i>Chamelaucium uncinatum</i>.

Journal of natural products·2025

Same author

Inflammatory burden index as a prognostic marker in patients with advanced gastric cancer treated with neoadjuvant chemotherapy and immunotherapy.

Frontiers in immunology·2025

Same author

Enhanced glucose homeostasis <i>via Clostridium symbiosum</i>-mediated glucagon-like peptide 1 inhibition of hepatic gluconeogenesis in mid-intestinal bypass surgery.

World journal of gastroenterology·2023

Search research articles

Related Experiment Videos

New antitumor compounds from Carya cathayensis.

Wei Wu¹, Xiu-Li Bi, Jia-Qing Cao

¹School of Traditional Chinese Medicine, Shenyang Pharmaceutical University, Shenyang 110016, People's Republic of China.

Bioorganic & Medicinal Chemistry Letters

|February 15, 2012

Summary

Researchers isolated novel lignans and phenolics from Carya cathayensis shells. Some compounds showed significant potential as antitumor agents, inhibiting cancer cell growth effectively.

Related Experiment Videos

Area of Science:

Natural Products Chemistry
Pharmacology
Organic Chemistry

Background:

Carya cathayensis shells are a source of bioactive natural products.
Lignans and phenolics possess diverse biological activities, including potential anticancer properties.

Purpose of the Study:

To isolate and characterize novel compounds from Carya cathayensis shells.
To evaluate the cytotoxic activity of isolated compounds against various human cancer cell lines.

Main Methods:

Isolation of compounds using chromatographic techniques.
Structure elucidation via 1D and 2D NMR spectroscopy and mass spectrometry.
Cytotoxicity assays against colorectal (HCT-116, HT-29), lung (A549), and breast (MCF-7) cancer cell lines.

Main Results:

A new lignan and three new phenolics (carayensin-A, -B, -C) were identified, along with 13 known compounds.
Compounds 1, 5, 6, and 16 demonstrated significant dose-dependent inhibition of cancer cell growth.
Specific activity was observed against human colorectal, lung, and breast cancer cell lines.

Conclusions:

Carya cathayensis shells yield structurally diverse bioactive compounds.
Certain isolated lignans and phenolics show promising antitumor potential.
Further investigation is warranted to explore these compounds as novel anticancer therapeutics.